Jul 8th 2010
Kiadis Pharma receives IND approval from FDA to start pivotal clinical trial with ATIR™
(NL version)
Apr 28th 2010
Kiadis Pharma Provides ATIR™ Update: Two Year Follow-Up Data Show No Cases of Transplant Related Mortality - FDA grants ATIR™ Orphan Drug Status as a Medicinal Cell Based Therapy to Reduce Transplant Related Mortality
(NL version)
Kiadis Pharma Press Releases
Kiadis Pharma Press Releases are available via an RSS feed. To add this RSS feed to your reader, right click on the RSS button, click "Copy Shortcut" and add the URL to your feed reader.
